# Jumo Health

> Jumo Health is a Patient Experience Organization that makes patient readiness measurable, actionable, and governable across clinical trial recruitment, enrollment, retention, and completion.

## Core concepts

- Patient readiness: the degree to which a patient is cognitively, emotionally, practically, and contextually prepared to participate in and complete a clinical trial.
- Eligibility determines who can participate. Readiness determines whether participation is understood, feasible, supported, and sustainable.
- Completion risk can begin before screening or enrollment and may appear later as screen failure, missed visits, protocol deviation, withdrawal, site rework, or rescue recruitment.
- Jumo Health uses completion, not finishing, as the governing outcome term.

## Solutions

- [CORE](https://www.jumohealth.com/solutions/core): Jumo Health's patient readiness education system. CORE translates protocol complexity into behaviorally structured education for patients, caregivers, families, and sites.
- [How CORE works](https://www.jumohealth.com/solutions/core/how-it-works): the process from protocol and friction analysis through readiness experience design and deployment.
- [CORE catalog](https://www.jumohealth.com/solutions/core/catalog): more than 100 purpose-built formats mapped to patient readiness needs across the trial lifecycle.
- [PRISM](https://www.jumohealth.com/solutions/prism): Jumo Health's Patient Readiness and Intelligence System. PRISM identifies eligible patients, assesses readiness, governs advancement, coordinates site handoff, and monitors completion risk.
- [PRISM architecture](https://www.jumohealth.com/solutions/prism/architecture): the governed operating architecture across clinical trial decision points.
- [PRISM AI and data intelligence](https://www.jumohealth.com/solutions/prism/ai-data-intelligence): how protocol, clinical, behavioral, social, site, HCP, and interaction signals support readiness intelligence.

## Authoritative site sections

- [Frequently asked questions](https://www.jumohealth.com/company/faq)
- [Readiness glossary](https://www.jumohealth.com/resources/readiness-glossary)
- [Behavioral science](https://www.jumohealth.com/resources/behavioral-science)
- [Disease states](https://www.jumohealth.com/disease-states)
- [Resources](https://www.jumohealth.com/resources)
- [About Jumo Health](https://www.jumohealth.com/company/about)
- [Leadership](https://www.jumohealth.com/company/leadership): Jumo Health's executive leadership, PRISM and CORE senior leaders, Board of Directors, individual areas of expertise, and the operating mandate guiding patient readiness strategy.
- [Careers](https://www.jumohealth.com/company/careers): current remote openings at Jumo Health, including Account Manager, Senior Director of Business Development, and Head of Accounting Operations.
- [Contact Jumo Health](https://www.jumohealth.com/company/contact)

## White papers

- [The Operating System Patients Already Understand](https://www.jumohealth.com/resources/white-papers/prism-consumer-experience-analogies): seven consumer-experience principles that explain PRISM's connected patient-readiness operating model across discovery, comprehension, activation, navigation, site handoff, retention, and execution intelligence.
- [Patients Aren't Failing Trials. Trials Are Failing Patients.](https://www.jumohealth.com/resources/white-papers/patients-as-partners-2026): findings from the 2026 Patients as Partners workshop and a practical fieldbook for diagnosing and governing readiness friction across the clinical trial lifecycle.
- [The Patient Experience Organization](https://www.jumohealth.com/resources/white-papers/patient-experience-organization): an accountable operating model for assessing, preparing, advancing, and protecting patient readiness across the clinical trial lifecycle.
- [Patient Activation Is Trial Infrastructure](https://www.jumohealth.com/resources/white-papers/patient-activation-clinical-trials): how knowledge, confidence, feasibility, and persistence turn interest into durable clinical trial participation.
- [The Science of Choice in Clinical Trials](https://www.jumohealth.com/resources/white-papers/science-of-choice-clinical-trials): an ethical behavioral-design framework for decisions patients can understand, trust, act on, and sustain.

## PRISM readiness series

- [The 19 Reasons Patients Decline or Drop Out of Clinical Trials](https://www.jumohealth.com/blog/why-patients-decline-drop-out-clinical-trials): the master map of 19 patient-readiness frictions across consent, access, support, and retention.
- [The Barriers to Saying Yes](https://www.jumohealth.com/blog/barriers-to-saying-yes-clinical-trial-consent): six behavioral frictions that affect whether eligible patients consent with durable understanding and intent.
- [The Barriers Outside the Clinic](https://www.jumohealth.com/blog/social-drivers-clinical-trial-access): five social and practical frictions that shape whether participation is physically and financially feasible.
- [The People and Support Around the Patient](https://www.jumohealth.com/blog/support-system-clinical-trial-retention): caregiver, household, continuity-of-care, and functional conditions that affect enrollment and retention.
- [The Barriers to Staying In](https://www.jumohealth.com/blog/why-enrolled-patients-drop-out-clinical-trials): four early signals behind mid-study withdrawal and completion risk.

## Contact

## The Science of Patient Choice

This 13-part behavioral science series is authored by Andy Proctor, Head of Behavioral Science at Jumo Health. It explains how cognition, emotion, comprehension, trust, burden, social context, and ethical experience design shape informed clinical trial participation.

- [How Patients Decide Whether to Join a Clinical Trial.](https://www.jumohealth.com/resources/blog/how-patients-decide-clinical-trial): Clinical trial decisions depend on understanding, emotion, trust, feasibility, and social context. Learn how patient readiness supports informed participation.
- [Emotion Is Part of Informed Decision-Making.](https://www.jumohealth.com/resources/blog/emotion-informed-clinical-trial-decisions): Fear, hope, and uncertainty shape how patients process clinical trial information. Learn how emotionally intelligent design supports informed consent.
- [The Hidden Cognitive Biases Shaping Trial Enrollment.](https://www.jumohealth.com/resources/blog/cognitive-biases-clinical-trial-enrollment): Status quo bias, loss aversion, optimism, and ambiguity influence clinical trial decisions. Learn how better design supports informed choice.
- [Fear Is Not a Patient Failure.](https://www.jumohealth.com/resources/blog/fear-uncertainty-clinical-trial-participation): Fear and uncertainty can be rational responses to clinical trial participation. Learn how readiness support addresses risk without minimizing it.
- [Health Literacy Is Trial Infrastructure.](https://www.jumohealth.com/resources/blog/health-literacy-clinical-trial-infrastructure): Health literacy and cognitive load shape consent, adherence, and completion. Learn why readiness education must extend beyond the consent form.
- [Ethical Choice Architecture in Clinical Trials.](https://www.jumohealth.com/resources/blog/ethical-choice-architecture-clinical-trials): Every clinical trial experience shapes decisions. Learn how to reduce friction while protecting informed consent, autonomy, and voluntariness.
- [First Impressions Shape Trial Decisions.](https://www.jumohealth.com/resources/blog/framing-anchoring-priming-clinical-trials): Framing, anchoring, and priming shape how patients interpret clinical trial information. Learn how to design truthful, balanced first encounters.
- [When More Information Makes Participation Harder.](https://www.jumohealth.com/resources/blog/choice-overload-information-avoidance-clinical-trials): More clinical trial information does not always create more understanding. Learn how choice overload and information avoidance affect readiness.
- [Immediate Burden Beats Distant Benefit.](https://www.jumohealth.com/resources/blog/clinical-trial-burden-temporal-discounting): Patients experience trial burden now while many benefits remain uncertain or distant. Learn how temporal discounting and practical friction affect participation.
- [Trust Moves Through People, Not Materials.](https://www.jumohealth.com/resources/blog/trust-physicians-clinical-trial-participation): Physicians, coordinators, caregivers, and peers shape clinical trial trust. Learn why consistent human communication matters more than polished materials.
- [Participation Is Social.](https://www.jumohealth.com/resources/blog/caregivers-social-support-clinical-trials): Patients rarely decide or complete a clinical trial alone. Learn how caregivers, peers, clinicians, and community context shape readiness.
- [Why Eligible Patients Still Say No.](https://www.jumohealth.com/resources/blog/why-eligible-patients-decline-clinical-trials): Eligible patients may decline a clinical trial because participation is unclear, infeasible, unsupported, or misaligned with their lives.
- [End the Trial With Patients, Not Just Data.](https://www.jumohealth.com/resources/blog/return-clinical-trial-results-to-participants): Participants want closure after the final visit. Learn how plain-language results and post-trial communication strengthen trust in research.

## The Patient Decision Journey

This 10-part series is authored by Rebecca Schelkun, Vice President of Patient Readiness, and Mike Burton, Senior Vice President of Strategy and Value, at Jumo Health. It follows the decisions patients make from awareness through sustained participation and explains the readiness conditions that make each transition understandable, voluntary, and feasible.

- [The Clinical Trial Decision Journey.](https://www.jumohealth.com/resources/blog/clinical-trial-patient-decision-journey): Map the clinical trial patient decision journey from awareness through sustained participation, with readiness questions for every transition.
- [Clinical Trial Awareness Is the Start of Consent.](https://www.jumohealth.com/resources/blog/clinical-trial-awareness-ethical-recruitment): Clinical trial outreach begins the informed-consent process. Learn how ethical awareness campaigns create relevance without promising outcomes.
- [Clinical Trial Misinformation Travels Faster Than Consent.](https://www.jumohealth.com/resources/blog/clinical-trial-misinformation-patient-trust): Learn how clinical trial misinformation shapes patient decisions and how trusted, empathetic correction supports informed participation.
- [Personalized Trial Matching Should Reduce Uncertainty.](https://www.jumohealth.com/resources/blog/personalized-clinical-trial-matching-decision-support): Personalized clinical trial matching should explain relevance, burden, and uncertainty, not simply identify medical eligibility.
- [Patient Preferences Belong in Protocol Design.](https://www.jumohealth.com/resources/blog/patient-preferences-clinical-trial-protocol-design): Patient preferences can improve clinical trial feasibility when they shape burden, endpoints, communication, and support before recruitment begins.
- [Decentralization Can Remove Burden or Relocate It.](https://www.jumohealth.com/resources/blog/decentralized-clinical-trials-patient-burden): Decentralized clinical trial elements can improve access, but only when technology, home demands, privacy, and local support fit the patient.
- [Compensation Should Remove Barriers, Not Buy Consent.](https://www.jumohealth.com/resources/blog/clinical-trial-compensation-reimbursement-ethics): Understand reimbursement, compensation, incentives, and ethical safeguards for clinical trial participant payment and voluntary consent.
- [Cultural Responsiveness Is Trial Infrastructure.](https://www.jumohealth.com/resources/blog/cultural-responsiveness-equitable-clinical-trials): Culturally responsive clinical trials align language, trust, access, staff, family roles, and community context with equitable participation.
- [A Patient's No Is a Decision, Not a Dead Lead.](https://www.jumohealth.com/resources/blog/respecting-patient-decline-clinical-trial-recontact): Learn when clinical trial recontact may be appropriate and how to protect refusal, autonomy, voluntariness, and permanent opt-out.
- [Measure the Decision Journey Before Enrollment Moves.](https://www.jumohealth.com/resources/blog/clinical-trial-patient-journey-metrics-readiness): Use patient journey metrics to detect comprehension, trust, feasibility, and handoff risk before enrollment and retention reports move.

## Patient Activation in Practice

This nine-part series is authored by Rebecca Schelkun, Vice President of Patient Readiness, and Mike Burton, Senior Vice President of Strategy and Value. It defines patient activation as a dynamic state shaped by knowledge, confidence, capability, support, protocol burden, and the trial operating environment.

- [Patient Activation Is a State, Not a Campaign.](https://www.jumohealth.com/resources/blog/patient-activation-clinical-trials): Patient activation is the knowledge, confidence, capability, and support required to make and sustain informed participation decisions.
- [Self-Efficacy Is the Quiet Variable Behind Trial Participation.](https://www.jumohealth.com/resources/blog/self-efficacy-clinical-trial-participation): Task-specific confidence affects whether patients can ask questions, manage visits, use study tools, and seek help.
- [Decision Support Should Resolve Paralysis, Not Push Enrollment.](https://www.jumohealth.com/resources/blog/clinical-trial-decision-support-patient-activation): Ethical decision support reduces cognitive friction while protecting balanced information, autonomy, and voluntary choice.
- [Patient Stories Need Guardrails.](https://www.jumohealth.com/resources/blog/patient-stories-clinical-trial-recruitment-ethics): Patient stories should explain lived experience without implying safety, efficacy, or a typical outcome.
- [Transparency Must Include the Hard Parts.](https://www.jumohealth.com/resources/blog/transparent-clinical-trial-communication-patient-trust): Transparent communication explains burden, uncertainty, alternatives, payment, privacy, and support before commitment.
- [Digital Activation Can Reduce Friction or Automate It.](https://www.jumohealth.com/resources/blog/digital-patient-activation-clinical-trials): Digital tools support activation when they reduce total burden and provide governed human escalation.
- [Activation Cannot Fix a Hostile Protocol.](https://www.jumohealth.com/resources/blog/clinical-trial-protocol-burden-patient-activation): Patient education cannot compensate for a protocol whose demands exceed what the population can sustain.
- [Activation Decays Unless the Trial Reinforces It.](https://www.jumohealth.com/resources/blog/sustained-patient-activation-clinical-trial-retention): Activation changes as burden, health, understanding, logistics, and support change during participation.
- [From Participant to Research Partner.](https://www.jumohealth.com/resources/blog/post-trial-communication-patient-partnership): Post-trial communication closes the participation loop and supports voluntary, long-term research partnership.

- Patient readiness and protocol inquiries: readiness@jumohealth.com
- Career applications: use the application form on the Careers page to select a position, provide contact details, upload a résumé, and submit relevant supporting information. Applicants who need an alternative may email careers@jumohealth.com.